Search
Patexia Community

Innovation, Technology, and IP News

Recent Developments in Medical Casts

Written by: Alexander D. Zeng & Philip M. Nelson On October 5, 2023, the World Intellectual Property Organization published Cast21’s PCT application...

Patexia Insight 194: The Top Lateral Moves of PTAB Attorneys in 2023

The Patent Trial and Appeal Board (PTAB) holds a pivotal position within intellectual property law, wielding substantial influence over patent validity determinations and dispute...

The First FDA Approved, Chinese Developed, PD-1 Inhibitor For Nasopharyngeal Carcinoma

Written by: Jason J. Jardine On October 27th, 2023, the U.S. Food and Drug Administration (FDA) approved LOQTORZITM (toripalimab-tpzi), developed by Coherus BioSciences, Inc...

Tata Faces Trade Secrets Setback: $210M Damages in DXC Technology Case, Jury Says

Tata Consultancy Services (TCS), a prominent Indian software conglomerate, has recently been embroiled in a legal battle with DXC Technology, resulting in a substantial setback. A ...

FDA Issues Long-Overdue Regulations on Direct-To-Consumer Advertisements for Prescription Medications

  Written by: Lucas P. Koziol, Ph.D. & Michael L. Fuller On November 21, 2023, the FDA published its final rule changing how prescriptions medicines are advertised to...

Feed tagged as "Eastern District of Texas":
In TC Heartland LLC v. Kraft Foods Group Brands LLC, [16–341] (May 22, 2017), the Supreme Court reversed the Federal Circuit and held that for purposes of the... Read More »
In a few short years China’s patent system has gone from an IP rights wannabe to one of the most responsive and patent-friendly systems in the world... Read More »
Menu